HEADER SIGNALING PROTEIN 28-NOV-17 6F3G TITLE IRAK4 IN COMPLEX WITH INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: IRAK-4,RENAL CARCINOMA ANTIGEN NY-REN-64; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4; COMPND 9 CHAIN: B; COMPND 10 SYNONYM: IRAK-4,RENAL CARCINOMA ANTIGEN NY-REN-64; COMPND 11 EC: 2.7.11.1; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: IRAK4; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 GENE: IRAK4; SOURCE 14 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 15 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 16 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS IRAK4, KINASE, INHIBITOR, CANCER, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR Y.XUE,S.L.DEGORCE,G.R.ROBB,A.D.FERGUSON REVDAT 1 23-MAY-18 6F3G 0 JRNL AUTH S.L.DEGORCE,R.ANJUM,K.S.DILLMAN,L.DREW,S.D.GROOMBRIDGE, JRNL AUTH 2 C.T.HALSALL,E.M.LENZ,N.A.LINDSAY,M.F.MAYO,J.H.PINK,G.R.ROBB, JRNL AUTH 3 J.S.SCOTT,S.STOKES,Y.XUE JRNL TITL OPTIMIZATION OF PERMEABILITY IN A SERIES OF PYRROLOTRIAZINE JRNL TITL 2 INHIBITORS OF IRAK4. JRNL REF BIOORG. MED. CHEM. V. 26 913 2018 JRNL REFN ESSN 1464-3391 JRNL PMID 29398441 JRNL DOI 10.1016/J.BMC.2018.01.008 REMARK 2 REMARK 2 RESOLUTION. 2.37 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.37 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.13 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 28259 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.291 REMARK 3 R VALUE (WORKING SET) : 0.290 REMARK 3 FREE R VALUE : 0.314 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1384 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 14 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.37 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.46 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.86 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2909 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.3080 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2749 REMARK 3 BIN R VALUE (WORKING SET) : 0.3060 REMARK 3 BIN FREE R VALUE : 0.3432 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.50 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 160 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4420 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 49 REMARK 3 SOLVENT ATOMS : 71 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 59.87 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 72.48 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 7.88860 REMARK 3 B22 (A**2) : -16.11220 REMARK 3 B33 (A**2) : 8.22370 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.480 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.453 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.293 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.460 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.297 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.864 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.838 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4544 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6136 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1611 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 131 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 628 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4544 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 590 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5170 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.13 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.91 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.38 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|164 - A|265 } REMARK 3 ORIGIN FOR THE GROUP (A): -31.5824 -9.3698 -10.0160 REMARK 3 T TENSOR REMARK 3 T11: 0.3040 T22: -0.2927 REMARK 3 T33: -0.3040 T12: 0.1520 REMARK 3 T13: 0.0283 T23: -0.1308 REMARK 3 L TENSOR REMARK 3 L11: 1.4617 L22: 8.2481 REMARK 3 L33: 0.0000 L12: -2.9104 REMARK 3 L13: -0.3555 L23: 1.5839 REMARK 3 S TENSOR REMARK 3 S11: -0.1003 S12: -0.0273 S13: 0.1256 REMARK 3 S21: 0.0623 S22: 0.2161 S23: 0.1147 REMARK 3 S31: -0.5442 S32: -0.2356 S33: -0.1157 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { A|266 - A|458 } REMARK 3 ORIGIN FOR THE GROUP (A): -24.9989 -31.9946 -20.5892 REMARK 3 T TENSOR REMARK 3 T11: 0.0633 T22: -0.0961 REMARK 3 T33: -0.3040 T12: 0.0947 REMARK 3 T13: -0.0499 T23: 0.0113 REMARK 3 L TENSOR REMARK 3 L11: 2.8997 L22: 1.2036 REMARK 3 L33: 4.3431 L12: -0.1972 REMARK 3 L13: 1.3786 L23: -0.4635 REMARK 3 S TENSOR REMARK 3 S11: 0.0694 S12: 0.1682 S13: 0.0052 REMARK 3 S21: -0.2277 S22: 0.0745 S23: 0.2722 REMARK 3 S31: -0.0792 S32: -0.4921 S33: -0.1440 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: { B|164 - B|265 } REMARK 3 ORIGIN FOR THE GROUP (A): 15.5727 -44.5523 -8.4317 REMARK 3 T TENSOR REMARK 3 T11: 0.0824 T22: -0.2936 REMARK 3 T33: -0.3038 T12: 0.0465 REMARK 3 T13: -0.1520 T23: 0.0290 REMARK 3 L TENSOR REMARK 3 L11: 2.2947 L22: 2.1554 REMARK 3 L33: 2.9516 L12: 1.6994 REMARK 3 L13: -0.4343 L23: 0.5267 REMARK 3 S TENSOR REMARK 3 S11: 0.0902 S12: 0.3990 S13: -0.3837 REMARK 3 S21: 0.1438 S22: 0.1578 S23: -0.2020 REMARK 3 S31: 0.5436 S32: 0.4800 S33: -0.2479 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: { B|266 - B|458 } REMARK 3 ORIGIN FOR THE GROUP (A): 10.8399 -21.8310 -18.5412 REMARK 3 T TENSOR REMARK 3 T11: 0.1691 T22: -0.1988 REMARK 3 T33: -0.3040 T12: -0.0591 REMARK 3 T13: 0.0992 T23: 0.0967 REMARK 3 L TENSOR REMARK 3 L11: 5.2747 L22: 2.0350 REMARK 3 L33: 4.6924 L12: -0.6976 REMARK 3 L13: 0.5979 L23: -0.7795 REMARK 3 S TENSOR REMARK 3 S11: 0.2921 S12: 0.5442 S13: 0.4728 REMARK 3 S21: -0.1902 S22: -0.2522 S23: -0.3443 REMARK 3 S31: -0.5438 S32: 0.5442 S33: -0.0399 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6F3G COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 28-NOV-17. REMARK 100 THE DEPOSITION ID IS D_1200007706. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-JUL-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28440 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.370 REMARK 200 RESOLUTION RANGE LOW (A) : 74.520 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 8.000 REMARK 200 R MERGE (I) : 0.12200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.37 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.73 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 8.20 REMARK 200 R MERGE FOR SHELL (I) : 0.74300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.76 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.60 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 50 MM HEPES PH 7.5, 0.02% REMARK 280 OCTYLGLUCOSIDE, 10% GLYCEROL, 0.3 M NACL, 1 MM TCEP, VAPOR REMARK 280 DIFFUSION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 43.75600 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 55.13850 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 71.06650 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 43.75600 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 55.13850 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 71.06650 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 43.75600 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 55.13850 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 71.06650 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 43.75600 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 55.13850 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 71.06650 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 188 REMARK 465 GLY A 189 REMARK 465 GLY A 195 REMARK 465 GLY A 196 REMARK 465 PHE A 197 REMARK 465 ALA A 217 REMARK 465 MET A 218 REMARK 465 VAL A 219 REMARK 465 ASP A 220 REMARK 465 ILE A 221 REMARK 465 GLY A 255 REMARK 465 ASP A 256 REMARK 465 SER A 336 REMARK 465 GLU A 337 REMARK 465 LYS A 338 REMARK 465 PHE A 339 REMARK 465 ALA A 340 REMARK 465 GLN A 341 REMARK 465 ALA B 216 REMARK 465 ALA B 217 REMARK 465 MET B 218 REMARK 465 VAL B 219 REMARK 465 ASP B 220 REMARK 465 ILE B 221 REMARK 465 THR B 222 REMARK 465 ASP B 254 REMARK 465 GLY B 255 REMARK 465 ASP B 256 REMARK 465 GLU B 337 REMARK 465 LYS B 338 REMARK 465 PHE B 339 REMARK 465 ALA B 340 REMARK 465 GLN B 341 REMARK 465 THR B 342 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OE1 GLU B 172 OE1 GLU B 172 4545 0.41 REMARK 500 CD GLU B 172 OE1 GLU B 172 4545 1.55 REMARK 500 CG GLU B 172 CG GLU B 172 4545 1.81 REMARK 500 CD GLU B 172 CD GLU B 172 4545 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 206 -107.94 56.67 REMARK 500 ARG A 310 -5.50 77.63 REMARK 500 ASP A 311 48.88 -147.65 REMARK 500 ASP A 329 82.28 57.35 REMARK 500 HIS A 390 48.53 -100.08 REMARK 500 ASP B 181 99.98 -51.91 REMARK 500 PHE B 197 40.65 -102.37 REMARK 500 ASN B 207 -7.84 66.40 REMARK 500 ARG B 310 -6.42 77.64 REMARK 500 ASP B 311 48.44 -146.40 REMARK 500 ASP B 329 81.24 59.11 REMARK 500 HIS B 390 48.95 -99.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CJN A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CJN B 502 DBREF 6F3G A 164 458 UNP Q9NWZ3 IRAK4_HUMAN 164 458 DBREF 6F3G B 164 458 UNP Q9NWZ3 IRAK4_HUMAN 40 334 SEQRES 1 A 295 ARG PHE HIS SER PHE SER PHE TYR GLU LEU LYS ASN VAL SEQRES 2 A 295 THR ASN ASN PHE ASP GLU ARG PRO ILE SER VAL GLY GLY SEQRES 3 A 295 ASN LYS MET GLY GLU GLY GLY PHE GLY VAL VAL TYR LYS SEQRES 4 A 295 GLY TYR VAL ASN ASN THR THR VAL ALA VAL LYS LYS LEU SEQRES 5 A 295 ALA ALA MET VAL ASP ILE THR THR GLU GLU LEU LYS GLN SEQRES 6 A 295 GLN PHE ASP GLN GLU ILE LYS VAL MET ALA LYS CYS GLN SEQRES 7 A 295 HIS GLU ASN LEU VAL GLU LEU LEU GLY PHE SER SER ASP SEQRES 8 A 295 GLY ASP ASP LEU CYS LEU VAL TYR VAL TYR MET PRO ASN SEQRES 9 A 295 GLY SER LEU LEU ASP ARG LEU SER CYS LEU ASP GLY THR SEQRES 10 A 295 PRO PRO LEU SER TRP HIS MET ARG CYS LYS ILE ALA GLN SEQRES 11 A 295 GLY ALA ALA ASN GLY ILE ASN PHE LEU HIS GLU ASN HIS SEQRES 12 A 295 HIS ILE HIS ARG ASP ILE LYS SER ALA ASN ILE LEU LEU SEQRES 13 A 295 ASP GLU ALA PHE THR ALA LYS ILE SER ASP PHE GLY LEU SEQRES 14 A 295 ALA ARG ALA SER GLU LYS PHE ALA GLN TPO VAL MET TPO SEQRES 15 A 295 SEP ARG ILE VAL GLY THR THR ALA TYR MET ALA PRO GLU SEQRES 16 A 295 ALA LEU ARG GLY GLU ILE THR PRO LYS SER ASP ILE TYR SEQRES 17 A 295 SER PHE GLY VAL VAL LEU LEU GLU ILE ILE THR GLY LEU SEQRES 18 A 295 PRO ALA VAL ASP GLU HIS ARG GLU PRO GLN LEU LEU LEU SEQRES 19 A 295 ASP ILE LYS GLU GLU ILE GLU ASP GLU GLU LYS THR ILE SEQRES 20 A 295 GLU ASP TYR ILE ASP LYS LYS MET ASN ASP ALA ASP SER SEQRES 21 A 295 THR SER VAL GLU ALA MET TYR SER VAL ALA SER GLN CYS SEQRES 22 A 295 LEU HIS GLU LYS LYS ASN LYS ARG PRO ASP ILE LYS LYS SEQRES 23 A 295 VAL GLN GLN LEU LEU GLN GLU MET THR SEQRES 1 B 295 ARG PHE HIS SER PHE SER PHE TYR GLU LEU LYS ASN VAL SEQRES 2 B 295 THR ASN ASN PHE ASP GLU ARG PRO ILE SER VAL GLY GLY SEQRES 3 B 295 ASN LYS MET GLY GLU GLY GLY PHE GLY VAL VAL TYR LYS SEQRES 4 B 295 GLY TYR VAL ASN ASN THR THR VAL ALA VAL LYS LYS LEU SEQRES 5 B 295 ALA ALA MET VAL ASP ILE THR THR GLU GLU LEU LYS GLN SEQRES 6 B 295 GLN PHE ASP GLN GLU ILE LYS VAL MET ALA LYS CYS GLN SEQRES 7 B 295 HIS GLU ASN LEU VAL GLU LEU LEU GLY PHE SER SER ASP SEQRES 8 B 295 GLY ASP ASP LEU CYS LEU VAL TYR VAL TYR MET PRO ASN SEQRES 9 B 295 GLY SER LEU LEU ASP ARG LEU SER CYS LEU ASP GLY THR SEQRES 10 B 295 PRO PRO LEU SER TRP HIS MET ARG CYS LYS ILE ALA GLN SEQRES 11 B 295 GLY ALA ALA ASN GLY ILE ASN PHE LEU HIS GLU ASN HIS SEQRES 12 B 295 HIS ILE HIS ARG ASP ILE LYS SER ALA ASN ILE LEU LEU SEQRES 13 B 295 ASP GLU ALA PHE THR ALA LYS ILE SER ASP PHE GLY LEU SEQRES 14 B 295 ALA ARG ALA SER GLU LYS PHE ALA GLN THR VAL MET TPO SEQRES 15 B 295 SEP ARG ILE VAL GLY THR THR ALA TYR MET ALA PRO GLU SEQRES 16 B 295 ALA LEU ARG GLY GLU ILE THR PRO LYS SER ASP ILE TYR SEQRES 17 B 295 SER PHE GLY VAL VAL LEU LEU GLU ILE ILE THR GLY LEU SEQRES 18 B 295 PRO ALA VAL ASP GLU HIS ARG GLU PRO GLN LEU LEU LEU SEQRES 19 B 295 ASP ILE LYS GLU GLU ILE GLU ASP GLU GLU LYS THR ILE SEQRES 20 B 295 GLU ASP TYR ILE ASP LYS LYS MET ASN ASP ALA ASP SER SEQRES 21 B 295 THR SER VAL GLU ALA MET TYR SER VAL ALA SER GLN CYS SEQRES 22 B 295 LEU HIS GLU LYS LYS ASN LYS ARG PRO ASP ILE LYS LYS SEQRES 23 B 295 VAL GLN GLN LEU LEU GLN GLU MET THR MODRES 6F3G TPO A 342 THR MODIFIED RESIDUE MODRES 6F3G TPO A 345 THR MODIFIED RESIDUE MODRES 6F3G SEP A 346 SER MODIFIED RESIDUE MODRES 6F3G TPO B 345 THR MODIFIED RESIDUE MODRES 6F3G SEP B 346 SER MODIFIED RESIDUE HET TPO A 342 11 HET TPO A 345 11 HET SEP A 346 10 HET TPO B 345 11 HET SEP B 346 10 HET CJN A 501 24 HET SO4 B 501 5 HET CJN B 502 24 HETNAM TPO PHOSPHOTHREONINE HETNAM SEP PHOSPHOSERINE HETNAM CJN ~{N}4,~{N}4-DIMETHYL-~{N}1-(5-PROPAN-2-YLPYRROLO[3,2- HETNAM 2 CJN D]PYRIMIDIN-4-YL)CYCLOHEXANE-1,4-DIAMINE HETNAM SO4 SULFATE ION HETSYN TPO PHOSPHONOTHREONINE HETSYN SEP PHOSPHONOSERINE FORMUL 1 TPO 3(C4 H10 N O6 P) FORMUL 1 SEP 2(C3 H8 N O6 P) FORMUL 3 CJN 2(C17 H27 N5) FORMUL 4 SO4 O4 S 2- FORMUL 6 HOH *71(H2 O) HELIX 1 AA1 SER A 169 THR A 177 1 9 HELIX 2 AA2 THR A 223 CYS A 240 1 18 HELIX 3 AA3 SER A 269 SER A 275 1 7 HELIX 4 AA4 CYS A 276 THR A 280 5 5 HELIX 5 AA5 SER A 284 ASN A 305 1 22 HELIX 6 AA6 LYS A 313 ALA A 315 5 3 HELIX 7 AA7 THR A 351 MET A 355 5 5 HELIX 8 AA8 ALA A 356 ARG A 361 1 6 HELIX 9 AA9 THR A 365 GLY A 383 1 19 HELIX 10 AB1 LEU A 395 LEU A 397 5 3 HELIX 11 AB2 ASP A 398 ASP A 405 1 8 HELIX 12 AB3 THR A 409 ILE A 414 1 6 HELIX 13 AB4 ASP A 422 LEU A 437 1 16 HELIX 14 AB5 LYS A 440 ARG A 444 5 5 HELIX 15 AB6 ASP A 446 THR A 458 1 13 HELIX 16 AB7 SER B 169 THR B 177 1 9 HELIX 17 AB8 PRO B 184 GLY B 188 5 5 HELIX 18 AB9 GLU B 224 CYS B 240 1 17 HELIX 19 AC1 SER B 269 SER B 275 1 7 HELIX 20 AC2 CYS B 276 THR B 280 5 5 HELIX 21 AC3 SER B 284 ASN B 305 1 22 HELIX 22 AC4 LYS B 313 ALA B 315 5 3 HELIX 23 AC5 THR B 351 MET B 355 5 5 HELIX 24 AC6 ALA B 356 ARG B 361 1 6 HELIX 25 AC7 THR B 365 GLY B 383 1 19 HELIX 26 AC8 LEU B 395 LEU B 397 5 3 HELIX 27 AC9 ASP B 398 ASP B 405 1 8 HELIX 28 AD1 THR B 409 ILE B 414 1 6 HELIX 29 AD2 ASP B 422 LEU B 437 1 16 HELIX 30 AD3 LYS B 440 ARG B 444 5 5 HELIX 31 AD4 ASP B 446 THR B 458 1 13 SHEET 1 AA1 6 HIS A 166 SER A 167 0 SHEET 2 AA1 6 LEU A 248 SER A 252 1 O PHE A 251 N HIS A 166 SHEET 3 AA1 6 CYS A 259 VAL A 263 -1 O VAL A 261 N LEU A 249 SHEET 4 AA1 6 THR A 208 LYS A 214 -1 N LYS A 213 O LEU A 260 SHEET 5 AA1 6 VAL A 199 VAL A 205 -1 N TYR A 201 O VAL A 212 SHEET 6 AA1 6 LYS A 191 GLY A 193 -1 N MET A 192 O VAL A 200 SHEET 1 AA2 2 ILE A 317 LEU A 319 0 SHEET 2 AA2 2 ALA A 325 ILE A 327 -1 O LYS A 326 N LEU A 318 SHEET 1 AA3 2 VAL A 343 MET A 344 0 SHEET 2 AA3 2 GLU A 363 ILE A 364 -1 O ILE A 364 N VAL A 343 SHEET 1 AA4 6 HIS B 166 SER B 167 0 SHEET 2 AA4 6 LEU B 248 SER B 252 1 O LEU B 249 N HIS B 166 SHEET 3 AA4 6 CYS B 259 VAL B 263 -1 O VAL B 261 N LEU B 249 SHEET 4 AA4 6 THR B 208 LYS B 214 -1 N LYS B 213 O LEU B 260 SHEET 5 AA4 6 VAL B 199 VAL B 205 -1 N TYR B 201 O VAL B 212 SHEET 6 AA4 6 LYS B 191 GLY B 193 -1 N MET B 192 O VAL B 200 SHEET 1 AA5 2 HIS B 307 ILE B 308 0 SHEET 2 AA5 2 ARG B 334 ALA B 335 -1 O ARG B 334 N ILE B 308 SHEET 1 AA6 2 ILE B 317 LEU B 319 0 SHEET 2 AA6 2 ALA B 325 ILE B 327 -1 O LYS B 326 N LEU B 318 LINK C TPO A 342 N VAL A 343 1555 1555 1.34 LINK C MET A 344 N TPO A 345 1555 1555 1.35 LINK C TPO A 345 N SEP A 346 1555 1555 1.36 LINK C SEP A 346 N ARG A 347 1555 1555 1.35 LINK C MET B 344 N TPO B 345 1555 1555 1.35 LINK C TPO B 345 N SEP B 346 1555 1555 1.34 LINK C SEP B 346 N ARG B 347 1555 1555 1.36 CISPEP 1 GLU A 392 PRO A 393 0 -1.12 CISPEP 2 GLU B 392 PRO B 393 0 -1.27 SITE 1 AC1 9 MET A 192 GLY A 193 ALA A 211 TYR A 262 SITE 2 AC1 9 VAL A 263 TYR A 264 MET A 265 ASP A 272 SITE 3 AC1 9 LEU A 318 SITE 1 AC2 4 ASP A 422 SER A 423 LYS B 174 ASN B 207 SITE 1 AC3 8 MET B 192 GLY B 193 ALA B 211 TYR B 262 SITE 2 AC3 8 VAL B 263 MET B 265 ASP B 272 LEU B 318 CRYST1 87.512 110.277 142.133 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011427 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009068 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007036 0.00000